Ko Yun-Fei,Martel Jan,Wu Tsung-Ru,Chang Chih-Jung,Lin Chuan-Sheng,Liau Jian-Ching,Wang Wei-Chang,Chiu Chen-Yaw,Lu Chia-Chen,Ojcius David Marcelo,Lai Hsin-Chih,Young John D.
申请号：
US201715815134
公开号：
US10111915(B1)
申请日:
2017.11.16
申请国别(地区):
美国
年份:
2018
代理人:
WPAT, PC
摘要：
The present invention describes a method to reduce blood aspartate transaminase level, liver weight, hepatic lipid accumulation and hepatocyte hypertrophy by administering the probiotic bacterium Parabacteroides goldsteinii to a subject showing signs of fatty liver disease. This probiotic bacterium can therefore be used to treat fatty liver disease.
